Inpatient Sleep Loss: Educating and Empowering Patients (ISLEEP)

May 15, 2023 updated by: University of Chicago

Mentoring Patient-Oriented Research: Sleep & Health During & After Hospital Stay

While many interventions have targeted hospital staff to improve sleep, few have been successful, and often suffer from limited adherence to staff protocols. Given preliminary data that suggests that empowered patients are more likely to obtain better sleep and have objectively lower noise levels in their rooms, it is plausible that partnering directly with patients can mitigate sleep loss and improve health outcomes. Patients will be randomized to receive the I-SLEEP education and empowerment program and test the effectiveness of this program on patient sleep and health outcome in the hospital and post-discharge. The aim of the project is to reduce environmental, healthcare-related, and patient-related factors that disrupt sleep of hospitalized patients by use of patient education and empowerment intervention.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

256

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60637
        • University Of Chicago Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Admitted to the general/hospitalist medicine departments
  • Stayed at least one night in hospital since admission

Exclusion Criteria:

  • Admitted >72 hours ago
  • Patient has been diagnosed with a sleep disorder such as narcolepsy, insomnia, or sleep apnea
  • Patient was transferred from ICU or outside hospital
  • Patient under strict, droplet, or airborne isolation precautions
  • Unable to ambulate
  • Too confused or incoherent to provide consent
  • Patient cannot speak English
  • Pregnancy
  • Residence in a nursing home or assisted living facility
  • Patient was admitted in a hospital within two weeks of current admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Sleep Kit Alone
Patients who are not randomized into the I-SLEEP intervention will receive a sleep kit that includes an eye mask, earplugs, and headphones.They will still receive the usual standard of care provided by clinicians which includes measures to reduce unnecessary nighttime disruptions and limiting excessive noise within the hospital setting.
Patients receive a small pouch that includes an eye mask, ear plugs, and headphones, all to be used to aid in falling/staying asleep
Experimental: Sleep Kit + Empowerment

A short video will be shown on iPads and a brochure will be given that both describe the importance of good sleep and how to facilitate it with good sleep hygiene.

The video will show a few reasons why someone might not get optimal sleep while in a hospital, and offer advice to address this from a doctor. The brochure will be kept to no higher than a 6th grade reading level, considered optimal for health education materials. Text will be kept brief and to the point. To account for vision problems, we will use >12-point font & leave a large portion of each page empty. Visual Aids & graphics will be employed when possible.

All of this is given in addition to the usual standard of care provided by clinicians.

Patients receive a small pouch that includes an eye mask, ear plugs, and headphones, all to be used to aid in falling/staying asleep
Group to receive a 5 minute video about typical hospital sleep disruptions and what they can do to prevent them, as well as a brochure outlining the importance of sleep

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Karolinska Sleep Log - Sleep Times
Time Frame: Through stay in the hospital until discharge, usually 2-3 days
A self-reported measure of time spent sleeping, time it took to fall asleep, etc.
Through stay in the hospital until discharge, usually 2-3 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of Sleep Disruptions in the Hospital Setting
Time Frame: Through stay in the hospital until discharge, usually 2-3 days
Administered to obtain a subjective view of typical disruptions to sleep such as bed comfort, room temperature, and pain. Items will also assess the disruptions that are caused by healthcare, such as vital signs, medication administration, and lab-work. This survey includes an item on how disruptive noise was to the patient's sleep, broken down into as many sources of hospital noise as possible.
Through stay in the hospital until discharge, usually 2-3 days
Patients Who Report Talking to Clinicians About Their Healthcare
Time Frame: Through stay in the hospital until discharge, usually 2-3 days
Measure of number of patients who advocate for their sleep by making lifestyle changes, including speaking to their clinicians to reduce nighttime disruptions
Through stay in the hospital until discharge, usually 2-3 days
Number of nighttime disruptions to sleep
Time Frame: Through stay in the hospital until discharge, usually 2-3 days
Measure of disruptions patients receive between 11 PM and 7 AM, determined by hospital hand sanitizer stations outside doors and electronic health record audits
Through stay in the hospital until discharge, usually 2-3 days
Karolinska Sleep Log - Outcomes of Sleep
Time Frame: Through stay in the hospital until discharge, usually 2-3 days
Subjective quality of sleep as determined by scales such as "On a scale of 1 to 5, with 5 being the most, how refreshed did you feel upon waking up this morning?"
Through stay in the hospital until discharge, usually 2-3 days
Actigraphy - Objective Measure of Sleep Duration
Time Frame: During stay at the hospital, for a week after, and for a week three months after discharge
Actiwatch Spectrum Pros used to determine sleep duration
During stay at the hospital, for a week after, and for a week three months after discharge
Actigraphy - Objective Measure of Sleep Quality
Time Frame: During stay at the hospital, for a week after, and for a week three months after discharge
Actiwatch Spectrum Pros used to determine sleep quality
During stay at the hospital, for a week after, and for a week three months after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vineet Arora, MD, MAPP, Medical Researcher

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2020

Primary Completion (Actual)

March 31, 2023

Study Completion (Actual)

March 31, 2023

Study Registration Dates

First Submitted

October 28, 2019

First Submitted That Met QC Criteria

November 1, 2019

First Posted (Actual)

November 5, 2019

Study Record Updates

Last Update Posted (Actual)

May 16, 2023

Last Update Submitted That Met QC Criteria

May 15, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IRB19-0169

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Deidentified data will be available to researchers by request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe